Current Neuropharmacology
Title: Current Neuropharmacology Volume 9, Supplement 1, September 2011
Volume: 9 Issue: 5
Author(s): Ferdinando Nicoletti
Affiliation:
Export Options
About this article
Cite this article as:
Nicoletti Ferdinando, Current Neuropharmacology Volume 9, Supplement 1, September 2011, Current Neuropharmacology 2011; 9 (5) . https://dx.doi.org/10.2174/1570159X11109050001
DOI https://dx.doi.org/10.2174/1570159X11109050001 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Progress Towards Recombinant Anti-Infective Antibodies
Recent Patents on Anti-Infective Drug Discovery Magnetic Resonance Imaging of Iron in Parkinsons Disease
Current Medical Imaging Opioid and Cannabinoid System in Food Intake
Current Pharmaceutical Design Identifying Patterns of Psychopathology and Pointing the Way to Effective Interventions
Adolescent Psychiatry Correlation Between Structure, Retention and Lipophilicity of Some Antidepressants: QSRR and QSAR Studies
Letters in Drug Design & Discovery Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease
Mini-Reviews in Medicinal Chemistry Recent US Patents on Extracellular Matrix in Tissue Engineering and Regenerative Medicine
Recent Patents on Regenerative Medicine Common and Less Common Peripheral Nerve Disorders Associated with Diabetes
Current Diabetes Reviews Exploring the Role of Gene Therapy for Neurological Disorders
Current Gene Therapy The Interaction Between Burn Injury and Vitamin D Metabolism and Consequences for the Patient
Current Clinical Pharmacology Gliogenesis and Glial Pathology in Depression
CNS & Neurological Disorders - Drug Targets Five Decades of Cuprizone, an Updated Model to Replicate Demyelinating Diseases
Current Neuropharmacology Sodium Hydrosulfide Post-conditioning Protects Hippocampal CA1 Neurons from Neuronal Cell Injury in the Rat Model of Transient Global Cerebral Ischemia Through Activation of Extracellular-regulated Kinases Signaling
Current Neurovascular Research Conductance and Resistance Vessels in Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Neuroprotective Role of Nanoparticles Against Alzheimer's Disease
Current Drug Metabolism Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Vitamin D and Cardio-Metabolic Risk Factors in Overweight Adults: An Overview of the Evidence
Current Pharmaceutical Design Increasing Expression of Heme Oxygenase-1 by Proteasome Inhibition Protects Astrocytes from Heme-mediated Oxidative Injury
Current Neurovascular Research Advances in the Discovery of Novel Positive Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
Recent Patents on CNS Drug Discovery (Discontinued)